TimothyJosephVoorheesMD, MSCR
Hematology • Columbus, OHHematologic Oncology
Assistant Professor of Internal Medicine - Clinical
Dr. Voorhees is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2121 Kenny Rd
Columbus, OH 43221- Is this information wrong?
Education & Training
Ohio State University HospitalResidency, Internal Medicine, 2014 - 2017- Ohio State University College of MedicineClass of 2014
Certifications & Licensure
OH State Medical License 2014 - 2025
NC State Medical License 2017 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Internal MedicineHematology
Clinical Trials
- Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma Start of enrollment: 2019 Sep 01
- CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma Start of enrollment: 2019 Sep 17
- Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma Start of enrollment: 2023 Jan 31
Roles: Sponsor-Investigator
- Join now to see all
Publications & Presentations
PubMed
- Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.Voorhees, T. J., Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Yi Wang, Kelsi Reynolds, Robert Bolz, Jessica Miao, Chunhua Song, Day...> ;Blood Advances. 2024 Mar 23
- SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell Program.Nathan Denlinger, Marcos de Lima, Timothy J Voorhees, Evandro Bezerra, Samantha Jaglowski> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 18
- Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia.Ansel Nalin, Qiuhong Zhao, Timothy Voorhees, David Bond, Yazeed Sawalha, Walter Hanel, Audrey Sigmund, Kaitlin Annunzio, Lapo Alinari, Robert Baiocchi, Kami Maddocks, ...> ;Frontiers in Oncology. 2023 Jan 1
- Join now to see all
Abstracts/Posters
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular TherapiesTimothy J Voorhees, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel AgentsTimothy J Voorhees, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective AnalysisTimothy J Voorhees, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- High Risk Cytogenetic and Immunohistochemistry Findings in Monomorphic Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplant _ a Single Center ...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Retrospective Cohort Study Analyzing the Safety and Efficacy of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Former FellowsJune 20th, 2021
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
